✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. NeurologyResearchAgingSafety Why This Matters This study provides evidence that cannabis use in older adults may...
Daily Digest: Last 7 Hours: Cannabis, Liver Disease, and the Policy Gaps That Still Haunt Patients — March 07, 2026
A synthesis of 12 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Cannabis compounds CBD and CBG may help reverse fatty liver disease, study finds
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDHempAging Why This Matters Clinicians treating patients with non-alcoholic fatty liver disease now have preliminary...
Study reveals cannabis compounds reduce threat of fatty liver disease | Health
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDTHCAging Why This Matters This research identifying specific cannabis compounds that may reduce hepatic steatosis...
Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CBDAnxietyResearchMental Health Why This Matters Clinicians treating older adults with anxiety disorders may now consider...
Study Finds No Link Between Lifetime Cannabis Use and Cognitive Decline in Older Adults
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologyAgingSafety Why This Matters Clinicians can reassure older adult patients that moderate lifetime cannabis use...
Cannabis use not linked to cognitive decline or dementia in older adults, study finds – leafie
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. NeurologyResearchAgingSafety Why This Matters This study provides reassurance for older adults considering cannabis for symptom...
Daily Digest: Last 4 Hours: Cannabinoids and Fatty Liver Disease Show Promise While Regulatory Gaps Widen Across States — March 06, 2026
A synthesis of 6 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Cannabis Compounds Exhibit Potential in Combatting Fatty Liver Disease
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCAging Why This Matters Clinicians managing patients with fatty liver disease now have preliminary evidence...
Daily Digest: Last 6 Hours: Cognitive Safety, Liver Disease Breakthroughs, and the Drug Testing Problem That Won’t Go Away — March 06, 2026
A synthesis of 20 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.